i-Base home
Search Menu
  • Home
  • HTB
  • Conference reports
  • 8th European Conference on Clinical Aspects and Treatment of HIV-infection, Athens, 28-31 October 2001

8th European Conference on Clinical Aspects and Treatment of HIV-infection, Athens, 28-31 October 2001

2 November 2001. Related: Conference reports, Conference index, EACS 8th Athens 2001.

Reports from the conference.

  • HIV drug resistance can develop under HAART at low levels of viraemia
  • Combinations of lopinavir/r and amprenavir in heavily treatment experienced patients
  • Further reports of benefits of polylactic acid for facial lipoatrophy
  • GigaHAART study shows benefit of treatment interruption prior to treatment with >7 drugs in highly treatment experienced patients
  • Tenofovir DF 907 study
  • The Max Cmin 1 trial: indinavir/ritonavir vs. saquinavir/ritonavir
  • No significant drug interactions found between tenofovir DF and indinavir, lopinavir/r, lamivudine, or efavirenz
  • Ritonavir corrects drug interaction between efavirenz and saquinavir
  • Lopinavir/r effective in naive patients after three years of treatment

Links to other websites are current at date of posting but not maintained.

  • HTB RSS
  • HIV drug resistance can develop under HAART at low levels of viraemia
  • Volume 2 Number 10 December 2001 PDF

Early access

  • Community response to decimated US funding for HIV vaccine research 6 June 2025
  • Gates Foundation commits to providing lenacapavir as PrEP next year 3 June 2025
  • All early access reports

Current issues

  • June 2025
  • May 2025
  • April 2025
  • Back issues

Special report

  • Latest news on the US crisis and its impact on global health 30 May 2025

More from HTB

  • Conference reports
  • Conference shortcuts
  • Articles by subject
  • PDFs
  • Subscribe
  • HTB homepage

Home

  • i-Base homepage
  • Donate

This website sets no cookies from us or anyone else.

Information on this website is provided by treatment advocates and offered as a guide only. Decisions about your treatment should always be taken in consultation with your doctor.

HIV i-BASE
About us - Contact - Cookies and privacy - Copyright waiver - Terms of use - Home
Registered charity number: 1081905. Company number: 3962064.

Search i-Base

Site navigation

Quick links
HIV positive
Donate
Feedback
Advice and information
Q and A
Guides
HIV meds
Glossary
Research reports
HTB
HTB South
Pipeline report
Publications and resources
Publications
Other resources
Translations
Slide sets
Order and subscribe
Advocates' network
UK-CAB
Training manual
i-Base
About us
Contact
News and updates
Sitemap
Home
Find us on Facebook
i-Base on Facebook